-
Reber Genetics' In-Depth Visit to Japan's Kaico Co., Ltd., Exploring Innovative Applications of Insect Cell Protein Expression Technology and Future Collaboration OpportunitiesReber Genetics' In-Depth Visit to Japan'...
Reber Genetics Co., Ltd., a leading animal vaccine R&D company, recently completed a succe... -
Reber Genetics Successfully Participates in the 2025 Asian Pig Veterinary Society Congress (APVS), Deepens International Exchange, and Looks Ahead to the Future of Swine HealthReber Genetics Successfully Participates...
Reber Genetics Co., Ltd., a leading animal vaccine research and development company, is pl... -
Chief Technology Officer, Dr. Frank Chang FOR IMMEDIATE RELEASE [City/Location, Date] – P&Y Livestock Services Co., Ltd. (CÔwas invited to participate in the "Disease Situation in Livestock and Poultry in 2025 and Updates on PCV and Salmonella" in VietnamChief Technology Officer, Dr. Frank Chan...
Dr. Chia-Jung Chang, Chief Technology Officer, was invited to participate in the "Disease ... -
Reber Genetics to Participate in APVS 2025, Deepening Partnership with Japan CorporationsReber Genetics to Participate in APVS 20...
Taipei, Taiwan – August 26, 2025 – Reber Genetics Co., Ltd. (Reber Genetics) today announc... -
Dr. Chia-Jung Chang, Chief Technology Officer, was invited to participate in the Workshop on Swine Disease Vaccines and Diagnostic Techniques hosted by Nong Lam University in VietnamDr. Chia-Jung Chang, Chief Technology Of...
On April 17–18, 2025, the Vaccinology and Diagnostic Techniques in Swine Workshop was held... -
Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virusEvaluation of the new commercial recombi...
-
The valid period of PRRSFREE PRRS subunit vaccine has been extend from 24 months to 36 monthsThe valid period of PRRSFREE PRRS subuni...
This site uses cookies to improve your browsing experience. By continuing to browse this site you are agreeing to our use of cookies. For further information, please refer to Privacy Policy.
